Injectsense reports first human implantation of its IOP sensor

Key Takeaways

• Researchers successfully completed the first human implantation of a remote intraocular pressure (IOP) sensor manufactured by Injectsense.
• The company is fine-tuning the device, with the goal of providing autonomous and continuous IOP measurement.

Researchers successfully completed the first human implantation of a remote intraocular pressure (IOP) sensor manufactured by Injectsense, according to a press release from the company. The wireless IOP-Connect device was implanted in a minimally invasive, sutureless procedure. A team of researchers in Chile, who were led by Juan Mura, MD, of Centro de La Vision, collected IOP data using an external reader, according to the release. The study will continue enrollment with a target goal of 20 total patients.

“Although safety is the primary focus of this study, we are also informing our product design to meet the expectations of ophthalmologists across the globe,” Ariel Cao, Injectsense president and CEO, said in the release. “We expect these sensors to be easily delivered in the doctor’s office.”

The company is fine-tuning the delivery tool of the device and is looking to incorporate its Injectpower SAS solid-state micro-battery. This would allow for autonomous and continuous IOP measurement. The final product will also include the use of smart glasses that will upload data from the device and charge it while only being worn for a few minutes per week, according to the release.

Edited by Miriam Kaplan, PhD

Source:

Healio Ocular Surgery News, August 27, 2024; see source article